Improvement in androgenetic alopecia in 53-76-year-old men using oral finasteride

    December 1999 in “International Journal of Dermatology
    Sarah Brenner, Hagit Matz
    Image of study
    TLDR Finasteride increases hair count in middle-aged and elderly men without causing sexual dysfunction.
    This study was a double-blind, placebo-controlled clinical trial conducted on 28 men between the ages of 53 and 76 with both benign prostatic hyperplasia (BPH) and androgenetic alopecia. The participants were split into two groups - one given finasteride 5 mg daily for 24 months and the other given a placebo. Hair counts showed that there was a gradual increase in hair count in the group receiving finasteride while the control group had a slow decline from baseline. The difference in mean hair count between the two groups was statistically significant at all points of time, indicating that finasteride can improve AGA in middle-aged and elderly men. Additionally, there were no reports of sexual dysfunction during the study.
    View this study on →

    Cited in this study

      Finasteride: The First 5α-Reductase Inhibitor

      research Finasteride: The First 5α-Reductase Inhibitor

      23 citations ,   July 1993 in “Pharmacotherapy”
      Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.